222 Recruiting Trials

Clinical Trials
in Hawaii

Browse 222 recruiting clinical trials currently enrolling participants in Hawaii. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 222 recruiting trials in Hawaii

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Recruiting
Connect for Cancer Prevention Study (Connect)
N/A Denver, Colorado +4 sites · Cancer, General Research Use
Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
PHASE2 Anchorage, Alaska +4 sites · Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7
Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
PHASE3 Fayetteville, Arkansas +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
PHASE3 Phoenix, Arizona +4 sites · Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
PHASE2 Chandler, Arizona +4 sites · Non-Small Cell Lung Cancer, c-MET
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
PHASE3 Birmingham, Alabama +4 sites · Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Myelodysplastic Syndrome
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
PHASE2 Birmingham, Alabama +4 sites · Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Recruiting
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
PHASE2 Dublin, California +4 sites · Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma
Recruiting
See all 222 results in Hawaii

Check Your Eligibility

Create a free profile and our AI will match you to trials in Hawaii you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in Hawaii
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon